Skip to content
Inciteful Med

The Underlying Causes of Non-Immune Hydrops Fetalis

Last updated:

Non-immune hydrops fetalis (NIHF) is not a single disease, but a symptom of an underlying health issue causing abnormal fluid buildup in a fetus. Identifying the exact cause—whether it is a heart defect, genetic disorder, or viral infection—is the critical step for determining treatment.

Key Takeaways

  • • Non-immune hydrops fetalis is a symptom of an underlying medical problem rather than a specific disease itself.
  • • Cardiovascular issues, such as structural heart defects and abnormal heart rhythms, cause about 20% of NIHF cases.
  • • Genetic conditions, chromosomal abnormalities, and viral infections like Parvovirus B19 are frequently identified triggers.
  • • Finding the specific underlying cause is essential because it dictates the baby's prognosis and available treatment options.
  • • In roughly one-third of cases, the exact cause remains unknown (idiopathic) despite extensive medical and genetic testing.

When you first hear the term non-immune hydrops fetalis (NIHF), it can sound like a single, specific disease. However, it is more accurate to think of NIHF as a symptom—much like a fever—that indicates an underlying medical issue [1]. Because NIHF is a “downstream” effect of many different conditions, the most important task for your medical team is to find the “upstream” cause [2].

Why Finding the Cause Matters

The underlying cause is the single most important factor in determining the prognosis (the likely outcome) and what treatment options are available [2][3]. For example, fluid caused by a treatable heart rhythm issue has a very different path forward than fluid caused by a chromosomal abnormality [4][5].

Major Categories of Causes

Doctors generally group the causes of NIHF into several categories. Identifying which category a case falls into helps narrow down the search for a specific diagnosis.

1. Cardiovascular Issues (approx. 20%)

Problems with the heart are among the most frequent causes of NIHF [6]. These are divided into:

  • Structural Defects: Physical abnormalities in the heart’s development, such as hypoplastic left heart syndrome [6][7].
  • Arrhythmias: Abnormal heart rhythms (too fast or too slow) that prevent the heart from pumping blood effectively [6][3].

2. Genetic and Chromosomal Abnormalities

This is a broad category that accounts for a large portion of cases, especially those discovered early in pregnancy [8].

  • Aneuploidy: An abnormal number of chromosomes (such as Down syndrome or Turner syndrome) [8][9].
  • Monogenic Disorders: Changes in a single gene. Common examples in NIHF include RASopathies (like Noonan syndrome) and variants in the PIEZO1 gene, which affects how fluid moves through the body [10][11].

3. Hematologic (Blood) Diseases

Conditions that cause severe fetal anemia can lead to hydrops because the heart has to work much harder to move thin blood [12]. A common example is alpha-thalassemia (Hb Bart’s disease), which is more frequent in certain ethnic populations [13][5].

4. Infections

Certain viruses can pass through the placenta and affect the baby’s ability to produce red blood cells or damage the heart muscle [14].

  • Parvovirus B19: Also known as “fifth disease,” this is a common cause of fetal anemia and hydrops [14][15].
  • CMV (Cytomegalovirus): Another viral infection that doctors routinely test for in NIHF cases [16][17].

5. Inborn Errors of Metabolism (IEM)

These are rare genetic conditions where the baby’s body cannot properly break down certain substances, leading to a toxic buildup in organs [18]. Examples include Mucopolysaccharidosis type VII (MPS VII) and Gaucher disease [19][20].

6. Structural Issues

Sometimes a physical blockage or abnormality causes fluid to back up.

  • Congenital Chylothorax: A leak in the lymphatic system that causes fluid to fill the chest [1].
  • Tumors: Rare tumors like teratomas can draw a massive amount of blood flow away from the baby’s circulation, leading to heart failure and hydrops [21].

When the Cause is Unknown (Idiopathic)

Despite modern advances, the cause remains “idiopathic” (unknown) in approximately 33% to 41% of cases even after extensive testing [22][23]. In these instances, doctors focus on monitoring the fluid levels and managing the symptoms to give the baby the best possible chance [24].

Return to Introduction

Frequently Asked Questions

Why is it important to find the underlying cause of non-immune hydrops fetalis?
Finding the exact cause is the most important factor in determining your baby's prognosis and treatment options. Different causes, such as a treatable heart rhythm issue versus a genetic condition, require entirely different medical approaches.
What are the most common causes of NIHF?
Cardiovascular issues, such as structural heart defects and abnormal heart rhythms, account for about 20% of cases. Genetic abnormalities, severe fetal anemia, and viral infections are also frequent causes of fetal fluid buildup.
Can viral infections during pregnancy cause fetal hydrops?
Yes, certain viruses that pass through the placenta can lead to hydrops fetalis. Parvovirus B19 and Cytomegalovirus (CMV) are common viral causes that doctors routinely test for when hydrops is discovered.
What does it mean if the cause of NIHF is idiopathic?
An idiopathic diagnosis means the exact cause of the fluid buildup remains unknown even after extensive medical testing. In these cases, which make up about a third of all NIHF diagnoses, doctors focus on closely monitoring fluid levels and managing symptoms.
What genetic tests are used to find the cause of hydrops fetalis?
Doctors typically start with chromosomal tests like a microarray to look for missing or extra pieces of DNA. If those results are normal, they may recommend Whole Exome Sequencing to check for specific single-gene disorders like Noonan syndrome.

Questions for Your Doctor

  • • Which of the major categories (cardiovascular, genetic, etc.) do you suspect is the most likely cause in our case?
  • • Is the hydrops currently considered 'isolated,' or have other structural issues been seen on the ultrasound?
  • • If the initial chromosomal tests (like CMA) are normal, what is the plan and timeline for starting Whole Exome Sequencing (WES)?
  • • Are there any specific infections, such as Parvovirus B19, that we should be testing for right now?
  • • Are there any in-utero treatments available for the cause you suspect?

Questions for You

  • • Has our doctor mentioned any findings beyond fluid buildup, such as a heart defect or a small chin?
  • • Do we have any history of blood disorders, like thalassemia, in either of our families?
  • • Am I experiencing any new symptoms like sudden, severe swelling or high blood pressure?
  • • How can we best support each other while we wait for the results of the more advanced genetic tests?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Outcome and etiology of fetal pleural effusion, fetal ascites and hydrops fetalis after fetal intervention: retrospective observational cohort from a single institution.

    Wu WJ, Ma GC, Chang TY, et al.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2024; (63(4)):536-543 doi:10.1002/uog.27501.

    PMID: 37767652
  2. 2

    Nonimmune hydrops fetalis: Genetic analysis and clinical outcome.

    Deng Q, Fu F, Yu Q, et al.

    Prenatal diagnosis 2020; (40(7)):803-812 doi:10.1002/pd.5691.

    PMID: 32267001
  3. 3

    Non-Immune Hydrops Fetalis in a Pregnant Woman with Chronic Alcohol Use: A Case Report.

    Nisa AS, Susiarno H, Winarno GNA, Adriansyah PNA

    International medical case reports journal 2025; (18()):969-975 doi:10.2147/IMCRJ.S529728.

    PMID: 40787126
  4. 4

    Antenatal shunting and outcomes in fetuses with non-immune hydrops fetalis.

    Fragala V, Sabale S, Ashoor G, et al.

    Journal of perinatal medicine 2025; doi:10.1515/jpm-2025-0198.

    PMID: 40851234
  5. 5

    Etiology and Outcome of non-immune Hydrops Fetalis in Southern China: report of 1004 cases.

    Meng D, Li Q, Hu X, et al.

    Scientific reports 2019; (9(1)):10726 doi:10.1038/s41598-019-47050-6.

    PMID: 31341179
  6. 6

    A Rare Association of Non-Compaction of the Ventricular Myocardium, and Non-Immune Hydrops Fetalis.

    Nandyal R, Moorthy G

    The Journal of the Oklahoma State Medical Association 2016; (109(4-5)):146-50.

    PMID: 27328555
  7. 7

    A case of vasculopathy of unknown etiology associated with fatal hydrops fetalis and review of the literature on intimomedial mucoid degeneration.

    Zaleski MP, Chu Y, Frauenhoffer E, et al.

    Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2018; (33()):39-44 doi:10.1016/j.carpath.2018.01.002.

    PMID: 29414431
  8. 8

    Genetic disorders and pregnancy outcomes of non-immune hydrops fetalis in a tertiary referral center.

    Guo D, He S, Lin N, et al.

    BMC medical genomics 2023; (16(1)):83 doi:10.1186/s12920-023-01505-y.

    PMID: 37081464
  9. 9

    Perinatal and one-year outcomes of non-immune hydrops fetalis by etiology and age at diagnosis.

    Ota S, Sahara J, Mabuchi A, et al.

    The journal of obstetrics and gynaecology research 2016; (42(4)):385-91 doi:10.1111/jog.12922.

    PMID: 26712114
  10. 10

    Diagnostic yield from prenatal exome sequencing for non-immune hydrops fetalis: A systematic review and meta-analysis.

    Al-Kouatly HB, Shivashankar K, Mossayebi MH, et al.

    Clinical genetics 2023; (103(5)):503-512 doi:10.1111/cge.14309.

    PMID: 36757664
  11. 11

    PIEZO1 is the most common monogenic etiology of non-immune hydrops fetalis detected by prenatal exome sequencing.

    Brewer CJ, Makhamreh MM, Shivashankar K, et al.

    Prenatal diagnosis 2023; (43(12)):1556-1566 doi:10.1002/pd.6451.

    PMID: 37902181
  12. 12

    Ten years' experience in prenatal diagnosis of α-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities.

    Li H, Wang J, Wang D, et al.

    International journal of hematology 2023; (118(3)):355-363 doi:10.1007/s12185-023-03643-6.

    PMID: 37477864
  13. 13

    Characterization of Hb Bart's Hydrops Fetalis Caused by - -SEA and a Large Novel α0-Thalassemia Deletion.

    He S, Li J, Huang P, et al.

    Hemoglobin 2018; (42(1)):61-64 doi:10.1080/03630269.2018.1434198.

    PMID: 29493331
  14. 14

    Human parvovirus B19 vertical infection and hydrops fetalis. A case report.

    Boggio GA, Moreno L, Di Cuatro N, et al.

    Archivos argentinos de pediatria 2025; (123(3)):e202410420 doi:10.5546/aap.2024-10420.eng.

    PMID: 39401166
  15. 15

    Dual pathology of parvovirus B19 infection and Aicardi-Goutières syndrome complicating non-immune hydrops fetalis.

    Shekhawat DS, Das S, Sharma C, et al.

    BMJ case reports 2025; (18(7)) doi:10.1136/bcr-2025-266781.

    PMID: 40744631
  16. 16

    Progressive non-immune hydrops fetalis associated with RASA1 mutation: prenatal imaging and genomic insights.

    Borthakur K, Mali N, Borthakur I

    BMJ case reports 2026; (19(2)) doi:10.1136/bcr-2025-270831.

    PMID: 41763666
  17. 17

    Molecular characterization of Hb H disease in southern Thailand.

    Nittayaboon K, Nopparatana C

    International journal of hematology 2018; (108(4)):384-389 doi:10.1007/s12185-018-2494-3.

    PMID: 30006733
  18. 18

    Inborn errors of metabolism in a cohort of pregnancies with non-immune hydrops fetalis: a single center experience.

    Bruwer Z, Al Riyami N, Al Dughaishi T, et al.

    Journal of perinatal medicine 2018; (46(9)):968-974.

    PMID: 28822227
  19. 19

    Evaluation of Non-Immune Fetal Hydrops in Resource Poor Country: Challenges Faced in Ascertaining the Etiology.

    Gowda M, Gupta A, Shreyanka HV, et al.

    Prenatal diagnosis 2025; (45(7)):939-950 doi:10.1002/pd.6813.

    PMID: 40344244
  20. 20

    Mucopolysaccharidosis type VII as a cause of recurrent Non-Immune Hydrops Fetalis: The first Tunisian case confirmed by Next-Generation Sequencing.

    Hizem S, Elaribi Y, Ben Slama S, et al.

    Clinica chimica acta; international journal of clinical chemistry 2021; (513()):68-70 doi:10.1016/j.cca.2020.12.027.

    PMID: 33382994
  21. 21

    Congenital metastatic neuroblastoma with placental involvement as a rare cause of non-immune fetal hydrops.

    Campillo-Ajenjo M, Pena-Burgos EM, Herrero Ruiz B, et al.

    The journal of obstetrics and gynaecology research 2024; (50(8)):1402-1407 doi:10.1111/jog.15968.

    PMID: 38747123
  22. 22

    An Investigation of the Etiologies of Non-Immune Hydrops Fetalis in the Era of Next-Generation Sequence-A Single Center Experience.

    Wei X, Yang Y, Zhou J, et al.

    Genes 2022; (13(12)) doi:10.3390/genes13122231.

    PMID: 36553497
  23. 23

    Non-immune hydrops fetalis: A retrospective analysis of 151 autopsies performed at a single center.

    Kaykı G, Güçer Ş, Akçören Z, et al.

    The Turkish journal of pediatrics 2018; (60(5)):471-477.

    PMID: 30968631
  24. 24

    Isolated non-immune hydrops fetalis: an observational study on complete spontaneous resolution, perinatal outcome, and long-term follow-up.

    Neveling S, Knippel AJ, Kozlowski P

    Archives of gynecology and obstetrics 2023; (308(2)):487-497 doi:10.1007/s00404-022-06731-w.

    PMID: 35994111

This page explains the potential causes of non-immune hydrops fetalis for educational purposes. Always consult your maternal-fetal medicine specialist or genetic counselor to understand your baby's specific diagnosis and testing options.

Stay up to date

Get notified when new research about Non-immune hydrops fetalis is published.

No spam. Unsubscribe anytime.